This image is not available for purchase in your country.

Human papillomavirus vaccine

Human papillomavirus vaccine

M715/0600

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

TIM VERNON, LTH NHS TRUST / SCIENCE PHOTO LIBRARY TIM VERNON, LTH NHS TRUST / SCIENCE PHOTO LIBRARY

Caption

Human papillomavirus vaccine. Close-up of a label on a Gardasil vaccine box. This is the world's first commercially available vaccine against diseases caused by the human papillomavirus (HPV). It works by using inactive virus particles, which trigger an immune response without causing any illness. Once the immune system has been exposed to the vaccine, it will be better prepared to prevent infection by the active virus. It is hoped that this vaccine will drastically reduce the number of HPV-related cancers, such as cervical cancer. After undergoing extensive research and clinical trials, this vaccine was approved for use on 8th June 2006.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}